Department of Otolaryngology-Head and Neck Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
PLoS One. 2022 Feb 15;17(2):e0263773. doi: 10.1371/journal.pone.0263773. eCollection 2022.
The survival rate of head and neck squamous cell carcinoma (HNSCC) patients with secondary primary malignancy (SPM) showed no significant improvement for decades, however, the impact of advances in diagnostic tools is rarely mentioned. This study investigated the clinical characteristic of HNSCC with SPM over a 27-year period especially from the perspective of diagnostic tools.
This study evaluated 157 HNSCC patients with SPM. The patients were divided into two groups according to the time of SPM diagnosis (Group A:1992-2003; Group B: 2004-2014). Age, gender, stage of first primary malignancy (FPM), SPM interval, overall survival, and disease-free survival were compared between groups.
Group B had significantly more SPM developed rate (p = 0.002), more SPM patients with advanced stage of FPM (p = 0.001), synchronous SPM (p = 0.006), and shorter SPM interval (p<0.001) compared to Group A. The survival rate in Group B was not significantly better than Group A.
Among patients diagnosed with HNSCC recently, more SPMs are diagnosed in a shorter time interval and in a more advanced stage. The overall advances in diagnostic tools cannot significantly improve SPM survival, however, it enables more patients to receive corresponding treatment.
头颈部鳞状细胞癌(HNSCC)患者继发第二原发恶性肿瘤(SPM)的生存率几十年来没有显著提高,但很少有人提到诊断工具的进步所带来的影响。本研究通过 27 年的时间调查了 HNSCC 伴 SPM 的临床特征,特别是从诊断工具的角度进行了研究。
本研究评估了 157 例 HNSCC 伴 SPM 患者。根据 SPM 诊断时间将患者分为两组(A 组:1992-2003 年;B 组:2004-2014 年)。比较两组患者的年龄、性别、首发恶性肿瘤(FPM)分期、SPM 间隔、总生存期和无病生存期。
B 组 SPM 发生率显著更高(p = 0.002),FPM 晚期 SPM 患者更多(p = 0.001)、同步 SPM 患者更多(p = 0.006)、SPM 间隔更短(p<0.001)。B 组的生存率与 A 组相比无显著差异。
与近期诊断的 HNSCC 患者相比,更多的 SPM 在更短的时间间隔内被诊断出来,且处于更晚期。整体诊断工具的进步并不能显著改善 SPM 的生存率,但它使更多的患者能够接受相应的治疗。